NAD+ and NADH in Neuronal Death
Author:
- 10 February 2007
- journal article
- review article
- Published by Springer Nature in Journal of Neuroimmune Pharmacology
- Vol. 2 (3) , 270-275
Abstract
Neuronal death is a key pathological event in multiple neurological diseases. Increasing evidence has suggested that NAD+ and NADH mediate not only energy metabolism and mitochondrial functions, but also calcium homeostasis, aging, and cell death. This article is written to provide an overview about the information suggesting significant roles of NAD+ and NADH in neuronal death in certain neurological diseases. Our latest studies have suggested that intranasal administration with NAD+ can profoundly decrease ischemic brain damage. These observations suggest that NAD+ administration may be a novel therapeutic strategy for some neurological diseases.Keywords
This publication has 64 references indexed in Scilit:
- Direct phosphorylation and regulation of poly(ADP-ribose) polymerase-1 by extracellular signal-regulated kinases 1/2Proceedings of the National Academy of Sciences, 2006
- Activation of the transient receptor potential M2 channel and poly(ADP-ribose) polymerase is involved in oxidative stress-induced cardiomyocyte deathCell Death & Differentiation, 2005
- Amyloid β‐peptide(1–42) and hydrogen peroxide‐induced toxicity are mediated by TRPM2 in rat primary striatal culturesJournal of Neurochemistry, 2005
- Poly(ADP‐ribose) polymerase‐1 activation in a primate model of multiple sclerosisJournal of Neuroscience Research, 2005
- PARG activity mediates intestinal injury induced by splanchnic artery occlusion and reperfusionThe FASEB Journal, 2005
- Mice Lacking the 110-kD Isoform of Poly(ADP-Ribose) Glycohydrolase Are Protected against Renal Ischemia/Reperfusion InjuryJournal of the American Society of Nephrology, 2005
- Book Review: Iron and Parkinson’s DiseaseThe Neuroscientist, 2002
- Deleterious network hypothesis of agingMedical Hypotheses, 1997
- A new hypothesis of neurodegenerative diseases: The deleterious network hypothesisMedical Hypotheses, 1996
- Parenteral application of NADH in Parkinson's disease: Clinical improvement partially due to stimulation of endogenous levodopa biosynthesisJournal of Neural Transmission, 1996